Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

COO, MYC / BCL2 Status and R-IPI Define a Group of Poor Prognosis DLBCL Patients in a Real-World Clinical Setting

Stefania Bettelli, Raffaella Marcheselli, Samantha Pozzi, MD, Luigi Marcheselli, Robel Papotti, Elisa Forti, M. Christina Christina Cox, MD PhD, Arianna Di Napoli, Tamar Tadmor, MD, Antonino Maiorana, Valentina Donati, MD, Sara Galimberti, MD PhD, Stefano Sacchi, MD

Blood (2019) 134 (Supplement_1): 1617.

https://doi.org/10.1182/blood-2019-125689

Published: 2019

Journal Articles

Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients

Stefania Bettelli, Raffaella Marcheselli, Samantha Manfredini, Alessia Bari, MD, Samantha Pozzi, MD, M. Christina Christina Cox, MD PhD, Luigi Marcheselli, Arianna Di Napoli, Ilana Levy, MD, Elisa Forti, Tamar Tadmor, MD, Antonino Maiorana, Stefano Sacchi, MD

Blood (2018) 132 (Supplement 1): 5308.

https://doi.org/10.1182/blood-2018-99-117973

Published: 2018

Journal Articles

Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of Final FDG-PET in Diffuse Large B Cell Lymphoma Patients

Raffaella Marcheselli, PhD, Antonella Franceschetto, MD, Alessia Bari, MD, Luigi Marcheselli, MS, Tamar Tadmor, MD, Samantha Pozzi, MD, Ilana Levy, MD, Patrizia Pizzichini, MD, Daniela Prosperi, MD, Maria Christina Cox, MD, Rosaria D'Apollo, MD, Lucia Massi, MD, Napoleone Prandini, MD, Stefano Sacchi, MD

Blood (2017) 130 (Supplement 1): 1576.

https://doi.org/10.1182/blood.V130.Suppl_1.1576.1576

Published: 2017

Journal Articles

The Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of the End of Treatment 18-FDG-PET in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Raffaella Marcheselli, Antonella Franceschetto, Luigi Marcheselli, Alessia Bari, Samantha Pozzi, Monica Barbolini, Virginia Rossetti, Rosaria D'Apollo, Napoleone Prandini, Stefano Sacchi

Blood (2016) 128 (22): 5406.

https://doi.org/10.1182/blood.V128.22.5406.5406

Published: 2016

Journal Articles

Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients

Alessia Bari, Luigi Marcheselli, Tamar Tadmor, Raffaella Marcheselli, Maria Christina Cox, MDPhD, Samantha Pozzi, Angela Ferrari, Luca Baldini, Paolo Gobbi, Massimo Federico, Aaron Polliack, Stefano Sacchi

Blood (2015) 126 (23): 3862.

https://doi.org/10.1182/blood.V126.23.3862.3862

Published: 2015

Journal Articles

Neutrophil to Lymphocyte Ratio at Diagnosis Is an Independent Prognostic Factor in Diffuse Large B-Cell Lymphoma: Results of a Large Multicenter Study Involving 931 Patients

Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Tamar Tadmor, Samantha Pozzi, Maria Christina Cox, MDPhD, Luca Baldini, Angela Ferrari, Paola Ferri, Massimo Federico, Aaron Polliack, Stefano Sacchi

Blood (2015) 126 (23): 1465.

https://doi.org/10.1182/blood.V126.23.1465.1465

Published: 2015

Journal Articles

Prognostic Score Based on Clinical and Biochemical Surrogates of Disease Status in DLBCL Trated with Chemo-Immunotherapy

Luigi Marcheselli, Alessia Bari, MD, Samantha Pozzi, MD, Raffaella Marcheselli, M. Christina Cox, MD, Luca Baldini, Prof, Stefano Luminari, MD, Stefano Sacchi, MD

Blood (2014) 124 (21): 3027.

https://doi.org/10.1182/blood.V124.21.3027.3027

Published: 2014

Journal Articles

Prognostic Role of Serum Albumin Level in DLBCL before and during the Rituximab Era. Retrospective GISL Study over 738 Cases

Luigi Marcheselli, Alessia Bari, MD, Samantha Pozzi, MD, Raffaella Marcheselli, Maria Christina Cox, MD, Luca Baldini, Prof, Stefano Luminari, MD, Stefano Sacchi, MD

Blood (2014) 124 (21): 5411.

https://doi.org/10.1182/blood.V124.21.5411.5411

Published: 2014

Journal Articles

Secondary Leukemia After Non-Hodgkin Lymphoma: A Systematic Review and a Meta-Analysis

Raffaella Marcheselli, MS, Alessia Bari, MD, Eliana Valentina Liardo, MD, Luigi Marcheselli, MS, Samantha Pozzi, MD, Stefano Sacchi, MD

Blood (2011) 118 (21): 5192.

https://doi.org/10.1182/blood.V118.21.5192.5192

Published: 2011

Journal Articles

Evaluation of Atypical Low Energy Fractures in Patients Affected by Multiple Myeloma Treated with Bispohosphonates

Samantha Pozzi, MD, Raffaella Marcheselli, MS, Alessia Bari, MD, Eliana Valentina Liardo, MD, Paola Bresciani, MD, Maria Teresa Donini, MD, Santo Neri, MD, Luciano Masini, Giuseppe Caparrotti, MD, Pellegrino Musto, Elisa Ferraris, MD, Daniela Petro, MD, Luigi Marcheselli, MS, Antonio Palumbo, MD, Stefano Sacchi, MD

Blood (2011) 118 (21): 5134.

https://doi.org/10.1182/blood.V118.21.5134.5134

Published: 2011

Journal Articles

Relative Survival and Incidence Based Mortality of Diffuse Large B-Cell Lymphoma (DLBCL) in Rituximab Era: Population Based Study From Modena Cancer Registry (MCR)

Luigi Marcheselli, MS, Raffaella Marcheselli, MS, Alessia Bari, Claudia Cirilli, Eliana Valentina Liardo, MD, Samantha Pozzi, Massimo Federico, MD, Stefano Sacchi, MD

Blood (2011) 118 (21): 5185.

https://doi.org/10.1182/blood.V118.21.5185.5185

Published: 2011

Journal Articles

Phase II Study of Velcade® Plus Mabthera® In Relapsed Follicular Lymphomas

Stefano Sacchi, Raffaella Marcheselli, Alessia Bari, Eliana Valentina Liardo, Stefano Luminari, Francesco Merli, Antonio Lazzaro, Santo Neri, Angelo Michele Carella, Alberto Fragasso, Simona Falorio, Gabriele Buda, Pellegrino Musto, MD, Matteo Dell’Olio, Luca Baldini

Blood (2010) 116 (21): 1801.

https://doi.org/10.1182/blood.V116.21.1801.1801

Published: 2010

Journal Articles

Second Malignancy After Treatment for Non-Hodgkin Lymphoma: a Systematic Review and a Meta-Analysis of Population-Based and Cohort Studies.

Stefano Sacchi, Monica Pirani, Luigi Marcheselli, Raffaella Marcheselli, Alessia Bari, Claudia Cirilli, Federico Massimo

Blood (2009) 114 (22): 1918.

https://doi.org/10.1182/blood.V114.22.1918.1918

Published: 2009

Journal Articles

Secondary Malignancies after Treatment of Aggressive Non-Hodgkin Lymphoma: A GISL Cohort Study on 1259 Patients.

Stefano Sacchi, MD, Luigi Marcheselli, MS, Alessia Bari, MD, Raffaella Marcheselli, BS, Samantha Pozzi, MD, Giovanni Quarta, MD, Nicola Di Renzo, MD, Alberto Fragasso, MD, Francesco Angrilli, MD, Massimo Federico, MD

Blood (2007) 110 (11): 522.

https://doi.org/10.1182/blood.V110.11.522.522

Published: 2007

Journal Articles

Incidence and Outcome of Chronic Myeloproliferative Disorders: A Population-Based Study from a Cancer Registry in Northern Italy.

Alessia Bari, MD, Raffaella Marcheselli, BS, Ivan Rashid, BS, Goretta Bonacorsi, MD, Orsola Bonanno, MD, Paola Temperani, BS, Giovanna Leonardi, MD, Massimo Federico, MD, Stefano Sacchi, MD

Blood (2007) 110 (11): 4650.

https://doi.org/10.1182/blood.V110.11.4650.4650

Published: 2007

Journal Articles

Incidence and Outcome of Myelodysplastic Syndromes in Province of Modena.

Alessia Bari, MD, Raffaella Marcheselli, BS, Ivan Rashid, BS, Goretta Bonacorsi, MD, Roberto Marasca, MD, Francesca Giacobbi, BS, Patrizia Zucchini, BS, Massimo Federico, MD, Stefano Sacchi, MD

Blood (2007) 110 (11): 4610.

https://doi.org/10.1182/blood.V110.11.4610.4610

Published: 2007

Journal Articles

Rituximab (R) in Combination with Fludarabine (F) and Cyclophosphamide (C) in Relapsed Follicular Lymphoma (FL) Patients (pts).Final Results of FC + R Phase II Trial by the GISL.

Stefano Sacchi, MD, Samantha Pozzi, MD, Raffaella Marcheselli, BS, Stefano Luminari, MD, Massimo Federico, MD, Alessandra Tucci, MD, Francesco Merli, MD, Loretta Orsucci, MD, Giulia Cervetti, MD, Ubaldo Occhini, MD, Marina Liberati, MD, Vincenzo Callea, MD, Maura Brugiatelli, MD, Luca Baldini, MD

Blood (2006) 108 (11): 2763.

https://doi.org/10.1182/blood.V108.11.2763.2763

Published: 2006

Journal Articles

Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.

Blood (2005) 106 (11): 5057.

https://doi.org/10.1182/blood.V106.11.5057.5057

Published: 2005

NARROW

COO, MYC / BCL2 Status and R-IPI Define a Group of Poor Prognosis DLBCL Patients in a Real-World Clinical Setting

Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients

Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of Final FDG-PET in Diffuse Large B Cell Lymphoma Patients

The Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of the End of Treatment 18-FDG-PET in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients

Neutrophil to Lymphocyte Ratio at Diagnosis Is an Independent Prognostic Factor in Diffuse Large B-Cell Lymphoma: Results of a Large Multicenter Study Involving 931 Patients

Prognostic Score Based on Clinical and Biochemical Surrogates of Disease Status in DLBCL Trated with Chemo-Immunotherapy

Prognostic Role of Serum Albumin Level in DLBCL before and during the Rituximab Era. Retrospective GISL Study over 738 Cases

Secondary Leukemia After Non-Hodgkin Lymphoma: A Systematic Review and a Meta-Analysis

Evaluation of Atypical Low Energy Fractures in Patients Affected by Multiple Myeloma Treated with Bispohosphonates

Relative Survival and Incidence Based Mortality of Diffuse Large B-Cell Lymphoma (DLBCL) in Rituximab Era: Population Based Study From Modena Cancer Registry (MCR)

Phase II Study of Velcade® Plus Mabthera® In Relapsed Follicular Lymphomas

Second Malignancy After Treatment for Non-Hodgkin Lymphoma: a Systematic Review and a Meta-Analysis of Population-Based and Cohort Studies.

Secondary Malignancies after Treatment of Aggressive Non-Hodgkin Lymphoma: A GISL Cohort Study on 1259 Patients.

Incidence and Outcome of Chronic Myeloproliferative Disorders: A Population-Based Study from a Cancer Registry in Northern Italy.

Incidence and Outcome of Myelodysplastic Syndromes in Province of Modena.

Rituximab (R) in Combination with Fludarabine (F) and Cyclophosphamide (C) in Relapsed Follicular Lymphoma (FL) Patients (pts).Final Results of FC + R Phase II Trial by the GISL.

Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only